Silexon
Silexon accelerates drug discovery by applying artificial intelligence to integrate large-scale drug data and guide experimental decisions. It combines machine learning and big-data analytics with a deep-enhanced drug development workflow to identify targets and prioritize candidates. Core offerings include drug target panorama reports, personalized cell therapy development, and small-molecule virtual screening powered by AI models and computational chemistry. Silexon operates as an AI-driven drug R&D service provider serving pharmaceutical and biotech companies.
Silexon
Silexon accelerates drug discovery by applying artificial intelligence to integrate large-scale drug data and guide experimental decisions. It combines machine learning and big-data analytics with a deep-enhanced drug development workflow to identify targets and prioritize candidates. Core offerings include drug target panorama reports, personalized cell therapy development, and small-molecule virtual screening powered by AI models and computational chemistry. Silexon operates as an AI-driven drug R&D service provider serving pharmaceutical and biotech companies.